ATE23269T1 - Stabile insulinzubereitungen und verfahren zu deren herstellung. - Google Patents
Stabile insulinzubereitungen und verfahren zu deren herstellung.Info
- Publication number
- ATE23269T1 ATE23269T1 AT82301207T AT82301207T ATE23269T1 AT E23269 T1 ATE23269 T1 AT E23269T1 AT 82301207 T AT82301207 T AT 82301207T AT 82301207 T AT82301207 T AT 82301207T AT E23269 T1 ATE23269 T1 AT E23269T1
- Authority
- AT
- Austria
- Prior art keywords
- manufacture
- insulin preparations
- insulin
- stable insulin
- preparations
- Prior art date
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title abstract 8
- 102000004877 Insulin Human genes 0.000 title abstract 4
- 108090001061 Insulin Proteins 0.000 title abstract 4
- 229940125396 insulin Drugs 0.000 title abstract 4
- 238000002360 preparation method Methods 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 abstract 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 abstract 1
- 229910052791 calcium Inorganic materials 0.000 abstract 1
- 239000011575 calcium Substances 0.000 abstract 1
- 229910052749 magnesium Inorganic materials 0.000 abstract 1
- 239000011777 magnesium Substances 0.000 abstract 1
- 159000000003 magnesium salts Chemical class 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 239000011701 zinc Substances 0.000 abstract 1
- 229910052725 zinc Inorganic materials 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Dental Preparations (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8107423 | 1981-03-10 | ||
| DK414381 | 1981-09-18 | ||
| EP82301207A EP0060141B1 (de) | 1981-03-10 | 1982-03-09 | Stabile Insulinzubereitungen und Verfahren zu deren Herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE23269T1 true ATE23269T1 (de) | 1986-11-15 |
Family
ID=26067363
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT82301207T ATE23269T1 (de) | 1981-03-10 | 1982-03-09 | Stabile insulinzubereitungen und verfahren zu deren herstellung. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US4472385A (de) |
| EP (1) | EP0060141B1 (de) |
| AT (1) | ATE23269T1 (de) |
| AU (1) | AU550068B2 (de) |
| CA (1) | CA1170990A (de) |
| CH (1) | CH652031A5 (de) |
| DE (1) | DE3274064D1 (de) |
| ES (1) | ES510245A0 (de) |
| FI (1) | FI78838C (de) |
| FR (1) | FR2501507B1 (de) |
| GB (1) | GB2094145B (de) |
| IE (1) | IE52904B1 (de) |
| IT (1) | IT1150639B (de) |
| NO (1) | NO157843C (de) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU588794B2 (en) * | 1983-12-16 | 1989-09-28 | Thomas Takemi Aoki | Insulin delivery method |
| PH23446A (en) * | 1986-10-20 | 1989-08-07 | Novo Industri As | Peptide preparations |
| DE3880346T2 (de) * | 1987-02-25 | 1993-07-29 | Novonordisk As | Insulinderivate. |
| US4789660A (en) * | 1987-09-10 | 1988-12-06 | American Home Products Corporation | Insulin administration using methyl and propyl paraben |
| DK0921812T4 (da) † | 1996-06-20 | 2012-04-02 | Novo Nordisk As | Insulinpræparater, som indeholder et halogenid |
| ZA984697B (en) | 1997-06-13 | 1999-12-01 | Lilly Co Eli | Stable insulin formulations. |
| DE69924232D1 (de) * | 1998-01-09 | 2005-04-21 | Novo Nordisk As | Stabilisierte insulin-zubereitungen |
| US20020156434A1 (en) * | 1998-03-13 | 2002-10-24 | Minimed Inc. | Stabilizing catheter for protein drug delivery |
| WO2003094956A1 (en) | 2002-05-07 | 2003-11-20 | Novo Nordisk A/S | Soluble formulations comprising monomeric insulin and acylated insulin |
| US20030226223A1 (en) | 2002-06-11 | 2003-12-11 | The Procter & Gamble Co. | High efficiency electric toothbrush |
| US7322066B2 (en) | 2003-07-16 | 2008-01-29 | Church & Dwight Co., Inc. | Electric toothbrushes having movable, intermittently movable, and fixed bristles |
| US20050050659A1 (en) | 2003-09-09 | 2005-03-10 | The Procter & Gamble Company | Electric toothbrush comprising an electrically powered element |
| US20050053895A1 (en) | 2003-09-09 | 2005-03-10 | The Procter & Gamble Company Attention: Chief Patent Counsel | Illuminated electric toothbrushes emitting high luminous intensity toothbrush |
| FR2896164B1 (fr) * | 2006-01-18 | 2008-07-04 | Flamel Technologies Sa | Formulation colloidale d'insuline longue action et sa preparation |
| US9018190B2 (en) | 2009-03-27 | 2015-04-28 | Adocia | Functionalized oligosaccharides |
| FR2943538B1 (fr) * | 2009-03-27 | 2011-05-20 | Adocia | Formulation a action rapide d'insuline recombinante humaine |
| US20130231281A1 (en) | 2011-11-02 | 2013-09-05 | Adocia | Rapid acting insulin formulation comprising an oligosaccharide |
| ES2670969T3 (es) | 2012-11-13 | 2018-06-04 | Adocia | Formulación de acción rápida de insulina que comprende un compuesto aniónico sustituido |
| US20150273022A1 (en) * | 2014-02-10 | 2015-10-01 | Biodel Inc. | Stabilized ultra-rapid-acting insulin formulations |
| FR3020947B1 (fr) | 2014-05-14 | 2018-08-31 | Adocia | Composition aqueuse comprenant au moins une proteine et un agent solubilisant, sa preparation et ses utilisations |
| US9795678B2 (en) | 2014-05-14 | 2017-10-24 | Adocia | Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compound |
| FR3043557B1 (fr) | 2015-11-16 | 2019-05-31 | Adocia | Composition a action rapide d'insuline comprenant un citrate substitue |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR892194A (fr) * | 1938-06-29 | 1944-03-30 | Ig Farbenindustrie Ag | Procédé de fabrication de préparations à base d'insuline |
| US2474729A (en) * | 1945-01-03 | 1949-06-28 | Rhone Poulenc Sa | Insulin preparations |
| US3102077A (en) * | 1953-08-19 | 1963-08-27 | Christensen Henry Marinus | Preparation of insulin containing 2.75 to 8 percent zinc content |
| DK98342C (da) * | 1959-06-16 | 1964-03-31 | Henry Marinus Dr Christensen | Fremgangsmåde til fremstilling af et insulinpræparat til peroral applikation. |
| US4196196A (en) * | 1978-06-19 | 1980-04-01 | Tiholiz Ivan C | Divalen/monovalent bipolar cation therapy for enhancement of tissue perfusion and reperfusion in disease states |
-
1982
- 1982-03-04 AU AU81114/82A patent/AU550068B2/en not_active Ceased
- 1982-03-09 FI FI820808A patent/FI78838C/fi not_active IP Right Cessation
- 1982-03-09 ES ES82510245A patent/ES510245A0/es active Granted
- 1982-03-09 IE IE536/82A patent/IE52904B1/en not_active IP Right Cessation
- 1982-03-09 CH CH1447/82A patent/CH652031A5/de not_active IP Right Cessation
- 1982-03-09 FR FR8203942A patent/FR2501507B1/fr not_active Expired
- 1982-03-09 NO NO820742A patent/NO157843C/no unknown
- 1982-03-09 EP EP82301207A patent/EP0060141B1/de not_active Expired
- 1982-03-09 DE DE8282301207T patent/DE3274064D1/de not_active Expired
- 1982-03-09 US US06/356,343 patent/US4472385A/en not_active Expired - Lifetime
- 1982-03-09 AT AT82301207T patent/ATE23269T1/de not_active IP Right Cessation
- 1982-03-09 CA CA000397937A patent/CA1170990A/en not_active Expired
- 1982-03-09 IT IT8220038A patent/IT1150639B/it active
- 1982-03-09 GB GB8206899A patent/GB2094145B/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| US4472385A (en) | 1984-09-18 |
| IT1150639B (it) | 1986-12-17 |
| AU550068B2 (en) | 1986-02-27 |
| AU8111482A (en) | 1982-09-16 |
| NO820742L (no) | 1982-09-13 |
| EP0060141A3 (en) | 1983-08-24 |
| EP0060141A2 (de) | 1982-09-15 |
| CH652031A5 (de) | 1985-10-31 |
| GB2094145A (en) | 1982-09-15 |
| IT8220038A0 (it) | 1982-03-09 |
| EP0060141B1 (de) | 1986-11-05 |
| CA1170990A (en) | 1984-07-17 |
| NO157843B (no) | 1988-02-22 |
| FI820808L (fi) | 1982-09-11 |
| DE3274064D1 (en) | 1986-12-11 |
| FI78838C (fi) | 1989-10-10 |
| FI78838B (fi) | 1989-06-30 |
| ES8302462A1 (es) | 1983-01-16 |
| GB2094145B (en) | 1984-12-05 |
| IE820536L (en) | 1982-09-10 |
| FR2501507B1 (de) | 1986-04-18 |
| IE52904B1 (en) | 1988-04-13 |
| FR2501507A1 (de) | 1982-09-17 |
| NO157843C (no) | 1988-06-01 |
| ES510245A0 (es) | 1983-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2094145B (en) | Stabilized insulin preparations and method for their production | |
| SE8300598D0 (sv) | Stabilized insulin solutions and method for their production | |
| ATE76288T1 (de) | Feste pharmaceutische zubereitung mit verlaengerter wirkstofffreigabe und verfahren zur herstellung. | |
| GR1001503B (el) | Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών. | |
| PT67861B (en) | Improvements in the process for the preparation of iodophor compounds and methods for stabilizing iodophor pharmaceutical compositions containing same | |
| IT8122859A0 (it) | Derivati dell'acido 2-idrossi-5-fenilazobenzoico, composizioni farmaceutiche che licontengono e procedimento per laloro preparazione. | |
| ES468525A1 (es) | Procedimiento para la obtencion de nuevas 2-alquilenaminodi-hidropiridinas | |
| PT85949A (en) | Process for the preparation of insulin compositions containing magnesium ions | |
| JPS54106424A (en) | N substituted omegaaaminoalkanoyllomegaa aminoalkanoic acid* its use and manufacture and drug containing it | |
| DE59009603D1 (de) | Verfahren zur Herstellung von Ascorbinsäure-2-phosphat bzw. dessen Salzen sowie Kaliummagnesium-L-ascorbat-2-phosphat als vorteilhaftes Salz von L-Ascorbinsäure-2-phosphat. | |
| JPS56154417A (en) | Use of 3,3'-azobis -(6-hydroxybenzoic acid) as drug and pharmaceutical composition containing it | |
| ATE23578T1 (de) | Verfahren zur herstellung von (omegafluorsulfonyl)-haloaliphatischen carbonsaeurefluoriden. | |
| JPS5545684A (en) | Novel derivative of 33*aminoethyl*phenol and its salt*their manufacture*their use as drug and pharmaceutic composition containing them | |
| IT7829910A0 (it) | Derivati dell'acido fosfonoso, procedimenti per la loro preparazione e loro impiego per combattere microorganismi. | |
| ATE44950T1 (de) | Polyprenylverbindungen, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
| JPS54117483A (en) | Novel derivative of 33phenyltetrahydropyridine and its salt*their manufacture*their application as drug and pharmaceutical composition containing them | |
| JPS57116098A (en) | Novel 3-aminosteroid derivative, salt, manufacture, intermediate, use as drug and composition containing same | |
| JPS5585579A (en) | Novel betaalactone* 22hydroxycyclopentane carboxylic acid derivative*its manufacture* its use as drug and medical composition containing it | |
| IL56442A (en) | Solvent vehicle for the parenteral administration of therapeutics containing an adipic acid ester,pharmaceutical compositions comprising said vehicle and their use in the prophylaxis and/or treatment of certain diseases | |
| ATE61222T1 (de) | Aspoxicillin enthaltende medizinalzubereitung, ein verfahren zu ihrer herstellung und ihre verwendung zur herstellung eines arzneimittels. | |
| SU1517173A1 (ru) | Антисептическое средство | |
| DK163663C (da) | Hydroxyethyl-azol-derivater til behandling af mykoser, disse forbindelsers anvendelse til fremstilling af laegemidler samt farmaceutisk praeparat indeholdende mindst en af forbindelserne | |
| JPS5535094A (en) | 22bromoo9*100dihydroergosine* its acid addition salt* their manufacture and medicine containing them | |
| FR2509611B1 (fr) | Nouvel agent anti-acide et composition pharmaceutique le contenant | |
| IT8248704A0 (it) | Derivati dell'acido cefalosporanico, loro preparazione e loro impiego come medicamenti |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |